Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect
- PMID: 35459969
- PMCID: PMC9028904
- DOI: 10.1007/s00134-022-06711-3
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect
Conflict of interest statement
I have no financial or non-financial competing interests to declare.
Comment in
-
The need to define "who" rather than "if" for ECMO in COVID-19.Intensive Care Med. 2022 Jul;48(7):979-980. doi: 10.1007/s00134-022-06732-y. Epub 2022 May 17. Intensive Care Med. 2022. PMID: 35579687 Free PMC article. No abstract available.
Comment on
-
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.Intensive Care Med. 2022 Apr;48(4):467-478. doi: 10.1007/s00134-022-06645-w. Epub 2022 Mar 3. Intensive Care Med. 2022. PMID: 35238946 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
